Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis

医学 放化疗 荟萃分析 病态的 基底细胞 肿瘤科 癌 新辅助治疗 内科学 完全响应 胃肠病学 化疗 癌症 乳腺癌
作者
Xing Gao,Hidde Overtoom,Ben M. Eyck,Shi-Han Huang,Daan Nieboer,Pieter Christiaan van der Sluis,Sjoerd M. Lagarde,Bas P. L. Wijnhoven,Yin‐Kai Chao,J. Jan B. van Lanschot
出处
期刊:British Journal of Surgery [Oxford University Press]
卷期号:111 (5) 被引量:3
标识
DOI:10.1093/bjs/znae083
摘要

OBJECTIVE: Locally advanced oesophageal squamous cell carcinoma can be treated with neoadjuvant chemoradiotherapy or chemotherapy followed by oesophagectomy. Discrepancies in pathological response rates have been reported between studies from Eastern versus Western countries. The aim of this study was to compare the pathological response to neoadjuvant chemoradiotherapy in Eastern versus Western countries. METHODS: Databases were searched until November 2022 for studies reporting pCR rates after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma. Multi-level meta-analyses were performed to pool pCR rates separately for cohorts from studies performed in centres in the Sinosphere (East) or in Europe and the Anglosphere (West). RESULTS: For neoadjuvant chemoradiotherapy, 51 Eastern cohorts (5636 patients) and 20 Western cohorts (3039 patients) were included. Studies from Eastern countries included more men, younger patients, more proximal tumours, and more cT4 and cN+ disease. Patients in the West were more often treated with high-dose radiotherapy, whereas patients in the East were more often treated with a platinum + fluoropyrimidine regimen. The pooled pCR rate after neoadjuvant chemoradiotherapy was 31.7% (95% c.i. 29.5% to 34.1%) in Eastern cohorts versus 40.4% (95% c.i. 35.0% to 45.9%) in Western cohorts (fixed-effect P = 0.003). For cohorts with similar cTNM stages, pooled pCR rates for the East and the West were 32.5% and 41.9% respectively (fixed-effect P = 0.003). CONCLUSION: The pathological response to neoadjuvant chemoradiotherapy is less favourable in patients treated in Eastern countries compared with Western countries. Despite efforts to investigate accounting factors, the discrepancy in pCR rate cannot be entirely explained by differences in patient, tumour, or treatment characteristics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
渡边卯卯完成签到,获得积分10
刚刚
Hello的应助被liu采纳,获得10
刚刚
dashuaicai完成签到,获得积分20
刚刚
kkk发布了新的文献求助10
刚刚
刚刚
wang完成签到,获得积分10
刚刚
刚刚
Lucas的应助被咩了个咩采纳,获得10
1秒前
黑猫黑猫发布了新的文献求助10
1秒前
午凌二发布了新的文献求助30
1秒前
1秒前
2秒前
2秒前
无极微光的应助被enuiu采纳,获得20
2秒前
元灿霓发布了新的文献求助10
3秒前
3秒前
科研小白发布了新的文献求助10
4秒前
仄言发布了新的文献求助10
4秒前
4秒前
S11f完成签到,获得积分10
4秒前
5秒前
斯文败类的应助被活泼的筝采纳,获得30
5秒前
情怀的应助被dadadaniu采纳,获得10
5秒前
bgdw1219发布了新的文献求助20
5秒前
吖吖发布了新的文献求助10
5秒前
852的应助被麦季采纳,获得10
5秒前
shaco发布了新的文献求助10
5秒前
5秒前
英勇秋完成签到,获得积分10
6秒前
星辰大海的应助被CT采纳,获得10
6秒前
萍05完成签到,获得积分10
6秒前
百里幻竹发布了新的文献求助10
7秒前
zdy完成签到,获得积分20
7秒前
7秒前
7秒前
夏木发布了新的文献求助10
7秒前
7秒前
Dikker完成签到,获得积分10
8秒前
XLC关闭了XLC的文献求助
8秒前
再睡5分钟发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047